Avanos Medical/$AVNS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Avanos Medical
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
Ticker
$AVNS
Sector
Primary listing
NYSE
Employees
2,287
Headquarters
Website
Avanos Medical Metrics
BasicAdvanced
$645M
-
-$1.57
1.09
-
Price and volume
Market cap
$645M
Beta
1.09
52-week high
$15.68
52-week low
$9.30
Average daily volume
614K
Financial strength
Current ratio
2.151
Quick ratio
1.172
Long term debt to equity
14.225
Total debt to equity
16.59
Interest coverage (TTM)
6.14%
Profitability
EBITDA (TTM)
86.8
Gross margin (TTM)
53.25%
Net profit margin (TTM)
-10.40%
Operating margin (TTM)
6.83%
Effective tax rate (TTM)
-10.12%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
2.69%
Return on equity (TTM)
-9.07%
Valuation
Price to revenue (TTM)
0.916
Price to book
0.83
Price to tangible book (TTM)
2.43
Price to free cash flow (TTM)
14.911
Free cash flow yield (TTM)
6.71%
Free cash flow per share (TTM)
0.931
Growth
Revenue change (TTM)
1.95%
Earnings per share change (TTM)
-81.53%
3-year revenue growth (CAGR)
0.83%
10-year revenue growth (CAGR)
3.26%
3-year earnings per share growth (CAGR)
13.50%
10-year earnings per share growth (CAGR)
-16.13%
What the Analysts think about Avanos Medical
Analyst ratings (Buy, Hold, Sell) for Avanos Medical stock.
Avanos Medical Financial Performance
Revenues and expenses
Avanos Medical Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Avanos Medical stock?
Avanos Medical (AVNS) has a market cap of $645M as of March 05, 2026.
What is the P/E ratio for Avanos Medical stock?
The price to earnings (P/E) ratio for Avanos Medical (AVNS) stock is 0 as of March 05, 2026.
Does Avanos Medical stock pay dividends?
No, Avanos Medical (AVNS) stock does not pay dividends to its shareholders as of March 05, 2026.
When is the next Avanos Medical dividend payment date?
Avanos Medical (AVNS) stock does not pay dividends to its shareholders.
What is the beta indicator for Avanos Medical?
Avanos Medical (AVNS) has a beta rating of 1.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.